The Phase 2b protocol used one dose per day for 12 weeks
Besides, you can check out our insightful blog to learn, What is the temperature danger zone for food
Since the oral form of the peptide is not available commercially and injection of the peptide is not approved by the FDA, no metabolism experiments could be performed in humans If we go back to the 2014 review of six randomized, double-blind, placebo-controlled trials involving just over 900 patients, we see the following results: AOD9604 had no effect on serum IGF-1 levels, which confirms the hypothesis that AOD9604 does not act via IGF-1
When doctors dont know best
The compound may work synergistically with NAD+ precursors like NMN or NR, potentially enhancing metabolic benefits
This muscle-sparing effect distinguishes it from many other fat loss approaches including some GLP-1 medications and severe caloric restriction